Joined in 2023 
82 
63 About this deal
Lip GYH, Freedman B, de Caterina R, Potpara TS. Stroke prevention in atrial fibrillation: past, present and future comparing the guidelines and practical decision-making. Thromb Haemost 2017;117:1230–9. Updated JSP 752: tri-service regulations for expenses and allowances with version 41 for January 2020. Guo Y, Guo J, Shi X, et al. Mobile health technology-supported atrial fibrillation screening and integrated care: a report from the mAFA-II trial long-term extension cohort. Eur J Intern Med 2020;82:105–11.
April 2015, delivered the Michaelides lecture, at the 30th International Meeting on Clinical Cardiology, organized by the Hellenic Heart Foundation; Athens, Greece Follow-up was performed according to the standard of care at each routine visit to the outpatient anticoagulation clinic or visits for the anticoagulation control. If the patient never attends to these visits, medical records and telephone calls were used to obtain the information needed and vital status, with no specific interventions and no specific visits for study purposes. Follow-up was extended for 2 years in ABC pathway adherent and non-adherent patients, with no difference between both groups. During this period, all adverse events were recorded. Of note, patients lost to follow-up were <1% of the overall sample and thus unlikely to skew results with a sensitivity analysis evaluating them as intention-to-treat.The new ESC guidelines emphasise the relevance of a tailored, holistic treatment strategy, based on the individual risk assessment and patient preferences. Shared decision-making requires educating and empowering patients by encouraging active involvement in the therapeutic process using in-depth discussion with patients and an explanation of the benefits and risks of available treatment strategies. The choice of optimal management strategy still remains a challenge, especially among AF patients at the highest risk of stroke and bleeding and requires further research. Research impact on improvements in healthcare is summarised in a University of Birmingham 2014 Research Excellence Framework (REF) Impact Case Study. Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation 2014;129:837–47. Nielsen PB, Skjøth F, Søgaard M, Kjældgaard JN, Lip GY*, Larsen TB*. Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study. BMJ. 2017 Feb 10;356:j510. doi: 10.1136/bmj.j510 [*joint senior authors]. As I have been out a few years my interpretations are just that, my own, however whilst serving there were a few times i was involved in interpreting regulations and putting cases forward where applicable.
January 2015, delivered the Sun Chieh Yeh Heart Foundation Lecture at the Opening Ceremony of the Cardiorhythm 2015 meeting in Hong Kong. Professor Lip is a clinical researcher, with a major interest into the epidemiology of atrial fibrillation (AF), as well as the pathophysiology of thromboembolism in this arrhythmia. Furthermore, he has been researching stroke and bleeding risk factors, and improvements in clinical risk stratification. The CHA 2DS 2-VASc and HAS-BLED scores - for assessing stroke and bleeding risk, respectively – were first proposed and independently validated following his research, and are now incorporated into international guidelines.
Get You Home Pay Calculator
Martin Lewis: What the Autumn Statement means for you – including wages, benefits, pensions, ISAs, housing, national insurance and more Currenttranslational research partnerships ongoingwith AstonUniversity in collaboration with life sciences for early and exploratorydevelopment of new drugs to modulate cardiac fibrosis (grant applicationsin process)
June 2016: Martin Green Lecture, Ottawa Heart Research Conference 2016: Translational Research in Atrial Fibrillation Guo Y, Wang H, Zhang H, et al. Mobile photoplethysmographic technology to detect atrial fibrillation. J Am Coll Cardiol 2019;74:2365–75. Potpara TS, Lip GYH, Blomstrom-Lundqvist C, et al. The 4S-AF scheme (stroke risk; symptoms; severity of burden; substrate): a novel approach to in-depth characterization (rather than classification) of atrial fibrillation. Thromb Haemost 2021;121:270–8. Yoon M, Yang PS, Jang E, Yu HT, Kim TH, Uhm JS, et al. Improved Population-Based Clinical Outcomes of Patients with Atrial Fibrillation by Compliance with the Simple ABC (Atrial Fibrillation Better Care) Pathway for Integrated Care Management: A Nationwide Cohort Study. Thromb Haemost. 2019;119(10):1695-703. Although there was no significant difference in age, patients non-adherent to the ABC pathway presented with more prevalent diabetes, heart failure, renal impairment, and vascular disease (both coronary and peripheral artery diseases), as well as with higher CHA 2DS 2-VASc and HAS-BLED scores, compared to adherent patients (Table 1).Huisman MV, Rothman KJ, Paquette M, Teutsch C, Diener HC, Dubner SJ, Halperin JL, Ma CS, Zint K, Elsaesser A, Bartels DB, Lip GY; GLORIA-AF Investigators. The Changing Landscape for StrokePrevention in AF: Findings From the GLORIA-AF Registry Phase 2. J Am Coll Cardiol. 2017 Feb 21;69(7):777-785. You’re eligible to receive GYH(S) pay if you commence on a permanent assignment in a Seagoing LSA Qualifying Units (SLQU), or serve on a temporary assignment for a period of 36 consecutive days or more in such a Unit, are eligible to accumulate GYH(S) journeys.
Great Deal 
New Comment